FuseMed Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

FuseMed General Information

Description

Developer of endovascular embolism drugs designed for the biological industry. The company's products include intravascular embolization, volume reduction, and repair products empowered by experienced industry experts, providing customers with reliable and effective products.

Contact Information

Website
www.fusemed.cn
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 36, Number 356 Zhengbo Road, Lingang New Area
  • China (China) Pilot Free Trade Zone
  • Shanghai, 201413
  • China
+86 021
Primary Industry
Drug Discovery
Corporate Office
  • 3rd Floor, Building 36, Number 356 Zhengbo Road, Lingang New Area
  • China (China) Pilot Free Trade Zone
  • Shanghai, 201413
  • China
+86 021

FuseMed Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FuseMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 09-Sep-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 20-Jul-2023 Completed Generating Revenue
2. Early Stage VC 18-Jan-2023 Completed Generating Revenue
1. Early Stage VC 02-Nov-2022 Completed Generating Revenue
To view FuseMed’s complete valuation and funding history, request access »

FuseMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FuseMed Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ruiling Private Equity Management PE/Buyout Minority
Fuyuan Investment (HHF) Venture Capital Minority
New Alliance Capital Growth/Expansion Minority
Shanghai Huayu Investment Management PE/Buyout Minority
To view FuseMed’s complete investors history, request access »

FuseMed FAQs

  • When was FuseMed founded?

    FuseMed was founded in 2020.

  • Where is FuseMed headquartered?

    FuseMed is headquartered in Shanghai, China.

  • What is the size of FuseMed?

    FuseMed has 60 total employees.

  • What industry is FuseMed in?

    FuseMed’s primary industry is Drug Discovery.

  • Is FuseMed a private or public company?

    FuseMed is a Private company.

  • What is FuseMed’s current revenue?

    The current revenue for FuseMed is .

  • How much funding has FuseMed raised over time?

    FuseMed has raised $1.39M.

  • Who are FuseMed’s investors?

    Ruiling Private Equity Management, Fuyuan Investment (HHF), New Alliance Capital, and Shanghai Huayu Investment Management have invested in FuseMed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process